Cisplatin, raltitrexed, levofolinic acid and 5-fluorouracil in locally advanced or metastatic squamous cell carcinoma of the head and neck: A phase I-II trial of the Southern Italy Cooperative Oncology Group (SICOG)

Annals of Oncology

Volumn 11, Issue 5, 2000, Pages 575-580

  Caponigro, F ^a   Comella, P ^a   Rivellini, F ^a   Avallone, A ^a   Budillon, A ^a   Di Gennaro, E ^a   Mozzillo, N ^a   Ionna, F ^a   De Rosa, V ^a   Manzione, L ^b   Comella, G ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b SAN CARLO HOSPITAL   (Italy)

Author keywords

5 fluorouracil; Cisplatin; Head and neck cancer; Levofolinic acid; Raltitrexed

Indexed keywords

CISPLATIN; FLUOROURACIL; FOLINIC ACID; RALTITREXED;

ADULT; AGED; ARTICLE; BLOOD TOXICITY; CLINICAL ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HEAD CANCER; HUMAN; ITALY; MALE; METASTASIS; NAUSEA; NECK CANCER; NEUTROPENIA; PATIENT COMPLIANCE; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; VOMITING;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; NEUTROPENIA; QUINAZOLINES; THIOPHENES; TREATMENT OUTCOME;

EID: 17944391490     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008339428733     Document Type: Article

References (23)

1. Merlano M, Corvò R, Margarino G et al. Combined chemotherapy and radiation therapy in advanced inoperable squamous-cell carcinoma of the head and neck. The final report of a randomized trial. Cancer 1941; 67: 915-21.
2. Merlano M, Vitale V, Russo R et al. Treatment of advanced squamous-cell carcinoma of the head and neck with alternated chemotherapy and radiotherapy. N Engl J Med 1992; 327: 1115-21.
3. Merlano M, Benasso M, Corvo R et al. Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous-cell carcinoma of the head and neck. J Natl Cancer Inst 1996; 88: 583-9.
4. Paccagnella A, Orlando A, Marchiori C et al. Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: A study by the Gruppo di Studio Sui Tumori della Testa E Del Collo. J Natl Cancer Inst 1994: 86: 265-72.
5. Toohill RJ. Anderson T, Byhardt RW. Cisplatin and fluorouracil as neoadjuvant therapy in head and neck cancer. Arch Otolaryngol Head Neck Surg 1987; 113: 758-61.
6. Martin M, Hazan A, Vergnes L et al. Randomized study of 5-fluorouracil and cisplatin as neoadjuvant therapy in head and neck cancer: A preliminary report. Int J Radiat Oncol Biol Phys 1990; 19: 973-5.
7. Dimery IW, Hong WK. Overview of combined modality therapies for head and neck cancer. J Natl Cancer Inst 1993; 85: 95-111.
8. Scanlon KJ, Neuman EM, Lu Y. Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells. Proc Natl Acad Sci USA 1986; 83: 8923-6.
9. Jacobs C, Lyman G, Velez-Garcia E et al. A phase III randomized study comparing cisplatin and 5-fluorouracil as single agent and in combination for advanced squamous-cell carcinoma of the head and neck. J Clin Oncol 1992; 10: 257-63.
10. Gebbia V, Testa A, Valenza R et al. A phase II study of levofolinic acid and fluorouracil plus cisplatin in patients with advanced head and neck carcinoma. Oncology 1993; 50: 490-4.
11. Vokes EE, Schilsky RL, Weichselbaum RR. Induction chemotherapy with cisplatin, fluorouracil and high-dose leucovorin for locally advanced head and neck cancer. J Clin Oncol 1990; 8: 241-7.
12. Cunningham D, Zalcberg J, Smith I et al. Tomudex (ZD 1694): A novel thymidylate synthase inhibitor with clinical antitumour activity in a range of solid tumours. Ann Oncol 1996; 7: 179-82.
13. Caponigro F, Avallone A, McLeod HL et al. Phase I and pharmacokinetic study of Tomudex combined with 5-fluorouracil + levofolinic acid in advanced head & neck and colorectal cancer. Clin Cancer Res 1999; 5: 3948-55.
14. Kelland LR, Kimbell R, Hardcastle A et al. Relationships between resistance to cisplatin and antifolates in sensitive and resistant tumour cell lines. Eur J Cancer 1995; 31: 981-6.
15. Spaulding MB, Fisher SG, Wolf GT. Department of Veterans Affairs Cooperative Laryngeal Cancer Study Group. Tumor response, toxicity, and survival after neoadjuvant organ-preserving chemotherapy for advanced laryngeal carcinoma. J Clin Oncol 1994; 12: 1592-9.
16. Vokes EE, Weichselbaum RR, Mick R et al. Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, leucovorin, and concomitant chemo-radiotherapy for locally advanced head and neck cancer. J Natl Cancer Inst 1992; 84: 877-82.
17. Schneider M, Etienne MC, Milano G et al. Phase II trial of cisplatin, fluorouracil, and pure folinic acid for locally advanced head and neck cancer: A pharmacokinetic and clinical survey. J Clin Oncol 1995; 13: 1656-62.
18. Clark JR, Busse PM, Norris CM et al. Induction chemotherapy with cisplatin, fluorouracil, and high-dose leucovorin for squamous-cell carcinoma of the head and neck: Long-term results. J Clin Oncol 1997; 15: 3100-10.
19. ten Bokkel Huinink D, Batenburg de Jong RJ, Verschuur HP et al. A phase I II study of tomudex and cisplatin in the treatment of patients with locally advanced or metastatic head and neck cancer. Proc Am Soc Clin Oncol 1999; 18: 1583a (Abstr).
20. Manegold C, Buchholz, E, Kloeppel R et al. Phase I dose escalating study of Tomudex and cisplatin in metastatic non-small-cell lung cancer: Preliminary results. Ann Oncol 1998; 9 (Suppl 4): 487a (Abstr).
21. Longo GSA, Izzo J, Chang YM et al. Pretreatment of colon carcinoma cells with Tomudex enhances 5-fluorouracil cytotoxicity. Clin Cancer Res 1998; 4: 469-73.
22. Budillon A, Barbarulo D, Di Gennaro E et al. In vitro cytotoxicity of Tomudex (TOM) in combination with 5-fluorouracil (5-FU) and levofolinic acid (LFA) in head and neck and colon cancer cell lines. Ann Oncol 1998; 9 (Suppl 4): 637a (Abstr).
23. Caponigro F, Comella P, Marcolin P et al. A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced or metastatic squamous-cell carcinoma of the head and neck. Cancer 1999; 85: 952-9.